Atrial Natriuretic Peptide Reduces the Severe Consequences of Coronary Artery Occlusion in Anaesthetized Dogs

[1]  Yongge Liu,et al.  Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? , 1998, Circulation.

[2]  J. Papp,et al.  Modification by bradykinin B2 receptor blockade of protection by pacing against ischaemia-induced arrhythmias. , 1997, European journal of pharmacology.

[3]  J. Papp,et al.  Bradykinin and endothelial-cardiac myocyte interactions in ischemic preconditioning. , 1997, The American journal of cardiology.

[4]  T. Rasmussen,et al.  Renal role of the endogenous natriuretic peptide system in acute congestive heart failure. , 1996, Journal of cardiac failure.

[5]  J. Parratt,et al.  Endothelial cells, nitric oxide and ischaemic preconditioning , 1996, Basic Research in Cardiology.

[6]  E. Fleck,et al.  Regulation and differential expression of neutral endopeptidase 24.11 in human endothelial cells. , 1995, Hypertension.

[7]  J. Parratt,et al.  Possibilities for the pharmacological exploitation of ischaemic preconditioning. , 1995, Journal of molecular and cellular cardiology.

[8]  K. Nakao,et al.  MOLECULAR BIOLOGY AND BIOCHEMISTRY OF NATRIURETIC PEPTIDE FAMILY , 1995, Clinical and experimental pharmacology & physiology.

[9]  C. Ibukiyama,et al.  The beneficial effects of atrial natriuretic peptide on arrhythmias and myocardial high-energy phosphates after reperfusion. , 1994, Cardiovascular research.

[10]  J. Parratt,et al.  KATP channels in ischaemic preconditioning. , 1994, Cardiovascular research.

[11]  G. Grover.  Protective effects of ATP sensitive potassium channel openers in models of myocardial ischaemia. , 1994, Cardiovascular research.

[12]  Y. Nakaya,et al.  Atrial natriuretic factor and isosorbide dinitrate modulate the gating of ATP-sensitive K+ channels in cultured vascular smooth muscle cells. , 1994, Circulation research.

[13]  T. Yoshimoto,et al.  Atrial and Brain Natriuretic Peptides in Cardiovascular Diseases , 1994, Hypertension.

[14]  I. Tikkanen,et al.  Endothelin antiserum decreases volume-stimulated and basal plasma concentration of atrial natriuretic peptide. , 1993, Circulation.

[15]  J. Parratt.  Endogenous myocardial protective (antiarrhythmic) substances. , 1993, Cardiovascular research.

[16]  J. Parratt,et al.  Preconditioning of the ischaemic myocardium; involvement of the l‐arginine nitric oxide pathway , 1992, British journal of pharmacology.

[17]  K. Kangawa,et al.  Role of endogenous ANP in sodium excretion in rats with experimental pulmonary hypertension. , 1992, The American journal of physiology.

[18]  J. Parratt,et al.  Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. , 1992, Cardiovascular research.

[19]  F. Cobb,et al.  Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans. , 1989, Circulation.

[20]  F. Cobb,et al.  Effects of Atrial Natriuretic Peptide on Transmural Blood Flow and Reactive Hyperemia in the Presence of Flow‐Limiting Coronary Stenosis in the Awake Dog: Evidence for Dilation of the Intramural Vasculature , 1989, Circulation research.

[21]  A. Baertschi,et al.  Acute hypoxemia stimulates atrial natriuretic factor secretion in vivo. , 1988, The American journal of physiology.

[22]  H. Jin,et al.  Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release. , 1988, The Journal of pharmacology and experimental therapeutics.

[23]  R. Bache,et al.  Effects of atrial natriuretic peptide on coronary vascular resistance in the intact awake dog. , 1988, Journal of the American College of Cardiology.

[24]  F. Cobb,et al.  Effects of Atrial Natriuretic Peptide on Proximal Epicardial Coronary Arteries and Coronary Blood Flow in Conscious Dogs , 1987, Circulation research.

[25]  J. Greenfield,et al.  Effect of atrial natriuretic factor on transmural myocardial blood flow distribution in the dog. , 1987, Circulation.

[26]  L. Szekeres,et al.  Effect of the blood supply to the normal noninfarcted myocardium on the incidence and severity of early postocclusion arrhythmias in dogs , 1987, Basic Research in Cardiology.

[27]  A. D. Bold,et al.  Atrial natriuretic factor: a hormone produced by the heart. , 1985, Science.

[28]  F. Murad,et al.  Effects of atrial natriuretic factor, sodium nitroprusside, and acetylcholine on cyclic GMP levels and relaxation in rat aorta. , 1985, European journal of pharmacology.

[29]  L. Opie.  Role of cyclic nucleotides in heart metabolism. , 1982, Cardiovascular research.

[30]  R Lazzara,et al.  The Pathophysiology of Malignant Ventricular Arrhythmias During Acute Myocardial Ischemia , 1974, Circulation.

[31]  J. Parratt.  Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. , 1994, Trends in pharmacological sciences.

[32]  D. Escande,et al.  K+ channel openers and 'natural' cardioprotection. , 1992, Trends in pharmacological sciences.

[33]  R. Bache,et al.  Effects of atrial natriuretic peptide in the canine coronary circulation. , 1988, Circulation research.

[34]  A. D. de Bold,et al.  Atrial natriuretic factor: a hormone produced by the heart. , 1985, Science.